Oncogenic HER2 fusions in gastric cancer

Table 1 A summary of patients with gastric cancer harboring HER2 fusions

Samples	Country	Sex	Age	Fusions*	TNM	Pathological type
GC196	China	M	76	ZNF207_ex2/HER2_ex18	T3N1M0	Mixed
431-9540474 T	China	M	63	MDK_ex4/HER2_ex11	T2N2M0	-
GC334	China	F	62	NOS2_ex2/HER2_ex2	T3N2M0	Diffused

*The amplification of MDK-HER2 was determined by aCGH, whereas the other two HER2 fusion amplifications were defined by FISH and IHC assays.

ISSN: 1479-5876